Market Insight

Neuvotion announced that it plans to launch its FDA-cleared NeuStim neurostimulation. technology later this year.
NeuStim provides non-invasive, high-resolution electrical stimulation to muscles for promoting recovery after stroke and spinal cord injury. The company designed NeuStim to electrically s

Endologix announced that it acquired the Pounce thrombectomy system from Surmodics, closing the deal on May 18.
Pounce, an FDA-cleared and commercially available fully mechanical thrombectomy platform, offers the non-surgical removal of thrombi and emboli from peripheral arteries. It comes in multipl

Novanta has agreed to acquire Riverpoint Medical for up to $1.45 billion to strengthen its position in the medical consumables market and enter the minimally invasive surgery segment.
The deal includes $1.2 billion upfront in cash plus a potential $250 million milestone payment expected in 2027. The

Olympus has agreed to acquire BioProtect in a $270m deal, giving the company a commercial device that will help expand its prostate cancer care provision.
Israel-based BioProtect’s lead product is Balloon Spacer, a system designed to provide consistent spacing between the prostate and other critical

Cornerstone Robotics announced that it received CE mark approval for its Sentire endoscopic surgical robotic platform.
European approval covers minimally invasive surgical procedures in general surgery, gynecology, thoracic and urology procedures. It marks the introduction of the Hong Kong-based comp

Microsure, a medical robotics company developing high-precision robot-assisted systems for microsurgery, announced the CE mark approval of its
MUSA-3 system and a leadership transition as the company enters a new phase in its growth. Alex Joseph will take on the role of Chief Executive Officer, succe

vVARDIS has announced a strategic minority investment from funds managed by Apollo, a global alternative asset management firm. The investment will support the company’s next phase of global growth and commercial expansion, including the continued rollout of its Curodont product line.
According to vV

Trinity Capital Inc., a leading international alternative asset manager, announced the commitment of $30 million in growth capital to Iantrek, a medical technology company and a leader in the bio-interventional ophthalmic surgery (BIOS) space.
Iantrek develops minimally invasive surgical technologies

Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, announced that it has entered into a definitive agreement to acquire Robocath, a venture-backed innovator of robotic technologies for interventional cardiology and neurointerventions.
This